Download presentation
Presentation is loading. Please wait.
Published bySofie Groen Modified over 5 years ago
1
Circulating Antipodocyte Antibodies in Membranous Nephropathy: New Findings
Corrado Murtas, MD, Landino Allegri, MD, Gian Marco Ghiggeri, MD American Journal of Kidney Diseases Volume 62, Issue 1, Pages (July 2013) DOI: /j.ajkd Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions
2
Figure 1 Serum positivity for selected antipodocyte antibodies after immunosuppressant therapy, subdivided by outcome categories. The cohort consisted of 22 patients with idiopathic MN; data are combined from specimens collected after 1 and/or 2 years from diagnosis (G.M.G., unpublished observations, 2012). Abbreviations and definitions: AENO, α-enolase; AR, aldose reductase; complete remission, proteinuria with protein excretion <0.3 g/d; n°: number of patients for each outcome category; no remission, proteinuria with protein excretion >3.5 g/d; partial remission, proteinuria with protein excretion >0.3-<3.5 g/d; PLA2r, M-type phospholipase A2 receptor; SOD2, superoxide dismutase 2. American Journal of Kidney Diseases , 12-15DOI: ( /j.ajkd ) Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.